Top section
Top section
International investors take most of the book for the first time as Zabłocki's investment firm says it expects to make no further sales
Despite rough market conditions and angst over rates, array of deals have been well taken
It is difficult to see issuance conditions growing much better in the foreseeable future
Data
More articles
More articles
More articles
-
Chinese biopharmaceuticals firm Akesobio is preparing to launch bookbuilding for its IPO next week, according to a source close to the deal. -
The controlling shareholder of South Korean entertainment company Studio Dragon raised W166.1bn ($136.2m) this week after selling a portion of its stake.
-
The top tier of emerging markets sovereigns are cramming into this week’s issuance window, as Abu Dhabi followed Qatar’s Tuesday blowout with a triple tranche bond deal of its own.
-
Singapore has imposed a month-long lockdown after a spike in coronavirus cases. Bankers say they were ready for the move — but deal flow will suffer. Rashmi Kumar reports.
-
Two Indonesian state-owned firms are planning $1bn loans, returning to the market despite a sharp rise in volatility as funding markets react to Covid-19. Bankers told GlobalCapital Asia that borrowers may need to scale back their ambitions. Pan Yue reports.
-
The government’s response to the coronavirus has forced me to spend more time at home. Unfortunately, my wife is doing the same thing.
Sub-sections
-
Sponsored by CAF – Development Bank of Latin America and the Caribbean
CAF gearing up to transform regional development
-
Sponsored by Emirates NBD Capital
Emirates NBD Capital: An unrivalled conduit for Middle East liquidity
-
-
Sponsored by European Investment Bank
European Investment Bank: Supporting sustainable development in North Africa
